BRIGHT MINDS BIOSCIENCES INC. - DRUG
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 14
Latest filed: Aug 17, 2026
| Form | Count |
|---|---|
| SCHEDULE 13G/A | 6 |
| 6-K | 5 |
| SCHEDULE 13D/A | 1 |
| SCHEDULE 13G | 1 |
| 4 | 1 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Aug 17, 2026 | 6-K | Jun 30, 2026 | 0001062993-26-004442 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | — | 0001172661-26-003688 | View |
| Aug 12, 2026 | SCHEDULE 13G/A | — | 0000919574-26-004968 | View |
| Jul 02, 2026 | SCHEDULE 13D/A | — | 0001062993-26-003506 | View |
| Jun 03, 2026 | 6-K | Mar 31, 2026 | 0001062993-26-003005 | View |
| Jun 02, 2026 | 6-K | Jan 20, 2026 | 0001062993-26-002975 | View |
| May 28, 2026 | 6-K | May 26, 2026 | 0002060755-26-000031 | View |
| May 20, 2026 | 6-K | Mar 31, 2026 | 0001062993-26-002801 | View |
| May 15, 2026 | SCHEDULE 13G | — | 0000902664-26-002546 | View |
| May 15, 2026 | SCHEDULE 13G/A | — | 0001274173-26-000134 | View |
| May 15, 2026 | SCHEDULE 13G/A | — | 0001274173-26-000135 | View |
| May 12, 2026 | SCHEDULE 13G/A | — | 0001213900-26-055371 | View |
| Apr 30, 2026 | 4 | Apr 28, 2026 | 0000929638-26-001708 | View |
| Apr 30, 2026 | SCHEDULE 13G/A | — | 0000929638-26-001709 | View |